Aster DM Healthcare inks O&M agreement to operate hospital in Mandya
The term of O&M is for 15 years with a lock in period of 5 years for the Company and 15 years for VHPL & Bharathi Education trust.
The term of O&M is for 15 years with a lock in period of 5 years for the Company and 15 years for VHPL & Bharathi Education trust.
For anaemia control in children (0-19 years) & resolves for Call to Action in this direction
J. B. Chemicals & Pharmaceuticals has informed that the acquisition of the Razel franchise from Glenmark Pharmaceuticals Limited has been successfully completed.
Miravo to remain a Canadian controlled and operated company following closing of the transaction
The scheme is subject to statutory and regulatory approvals as may be necessary.
None of the observations are related to data integrity and management believes that they are addressable
The advanced laboratory spread over 2,200 Square feet has multiple laboratory divisions including Hematology, Biochemistry, Clinical pathology, Serology and Microbiology
Her previous role at Novartis, where she was general manager, data & digital, in global drug development, also included accountability for driving the DCT strategy, programs and platforms
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
CINRYZE is plasma-derived C1-I NH approved for routine prevention (prophylaxis), short-term prevention or pre-procedure prevention, and acute attacks of HAE.
Subscribe To Our Newsletter & Stay Updated